Related references
Note: Only part of the references are listed.EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies
Francesca Pregnolato et al.
RHEUMATOLOGY (2021)
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis
Ziyi Yang et al.
LUPUS (2021)
The efficacy and safety of second-line treatments of refractory and/or high risk pregnant antiphospholipid syndrome patients. A systematic literature review analyzing 313 pregnancies
Amelia Ruffatti et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Antirheumatic medications in pregnancy and breastfeeding
Mehret Birru Talabi et al.
CURRENT OPINION IN RHEUMATOLOGY (2020)
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine
Jose Omar Latino et al.
LUPUS (2020)
Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome
Guilherme R. de Jesus et al.
LUPUS (2020)
Antiphospholipid syndrome: An update on risk factors for pregnancy outcome
Sara De Carolis et al.
AUTOIMMUNITY REVIEWS (2018)
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
Cristina Belizna et al.
AUTOIMMUNITY REVIEWS (2018)
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
HYdroxychloroquine to Improve Pregnancy Outcome in Women with AnTIphospholipid Antibodies (HYPATIA) Protocol: A Multinational Randomized Controlled Trial of Hydroxychloroquine versus Placebo in Addition to Standard Treatment in Pregnant Women with Antiphospholipid Syndrome or Antibodies
Karen Schreiber et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study
Arsene Mekinian et al.
AUTOIMMUNITY REVIEWS (2017)
Antiphospholipid syndrome
M. Khamashta et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2016)
Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome
Maria Laura Bertolaccini et al.
JOURNAL OF AUTOIMMUNITY (2016)
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy
Eleftheria Lefkou et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies
Savino Sciascia et al.
THROMBOSIS AND HAEMOSTASIS (2016)
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases
Jaume Alijotas-Reig et al.
AUTOIMMUNITY REVIEWS (2015)
Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?
Arsene Mekinian et al.
AUTOIMMUNITY REVIEWS (2015)
Effect of Hydroxychloroquine on Antiphospholipid Antibody-Induced Changes in First Trimester Trophoblast Function
Caroline R. Albert et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2014)
14th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends
Doruk Erkan et al.
AUTOIMMUNITY REVIEWS (2014)
Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study
Sylvie Bouvier et al.
BLOOD (2014)
Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies
T. Marchetti et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management
J. Alijotas-Reig
LUPUS (2013)
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies
Michael D. Lockshin et al.
ARTHRITIS AND RHEUMATISM (2012)
First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss
Kate Bramham et al.
BLOOD (2011)
Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study
Amelia Ruffatti et al.
RHEUMATOLOGY (2011)
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
G. Ruiz-Irastorza et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A novel antiphospholipid antibody agent?
Beverley J. Hunt
BLOOD (2010)
Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome
K. Bramham et al.
LUPUS (2010)
The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis
J. H. Rand et al.
LUPUS (2010)
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
S. S. Pierangeli et al.
LUPUS (2010)
Is Obstetric Antiphospholipid Syndrome a Primary Nonthrombotic, Proinflammatory, Complement-Mediated Disorder Related to Antiphospholipid Antibodies?
Jaume Alijotas-Reig et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2010)
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss A Systematic Review and Meta-Analysis
Panayiotis D. Ziakas et al.
OBSTETRICS AND GYNECOLOGY (2010)
Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression
Anselm Mak et al.
RHEUMATOLOGY (2010)
Antiphospholipid Antibodies Induce a Pro-Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway
Melissa J. Mulla et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2009)
Update of the guidelines for lupus anticoagulant detection
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics
G. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases
N. Costedoat-Chalumeau et al.
RHEUMATOLOGY (2007)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Safety of hydroxychloroquine in pregnant patients with connective tissue diseases - A study of one hundred thirty-three cases compared with a control group
N Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2003)
Treatment of pregnant patients with antiphospholipid syndrome
A Tincani et al.
LUPUS (2003)
Share Paper
